Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma

BACKGROUND: Refractory or relapsed Hodgkin's disease (HD) occurs in 10-50% of patients. The treatment of choice for these patients is high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT). Response to salvage chemotherapy (SCT) partial remission (PR) is necessary before...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrzad, Valiollah, Ashrafi, Farzaneh, Farrashi, Ali Reza, Pourmarjani, Reyhaneh, Dehghani, Mehdi, Shahsanaei, Armindokht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360016/
https://www.ncbi.nlm.nih.gov/pubmed/28401077
http://dx.doi.org/10.4103/2277-9175.201687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360016/
https://www.ncbi.nlm.nih.gov/pubmed/28401077
http://dx.doi.org/10.4103/2277-9175.201687

Ejemplares similares